UltraBattery sets new standard for HEVs

Jan 17, 2008
UltraBattery sets new standard for HEVs
Researcher, Rosalie Louey, prepares components for the UltraBattery in CSIRO laboratories. Image credit – CSIRO

The odometer of a low emission hybrid electric test vehicle today reached 100,000 miles as the car circled a track in the UK using the power of an advanced CSIRO battery system.

The UltraBattery combines a supercapacitor and a lead acid battery in a single unit, creating a hybrid car battery that lasts longer, costs less and is more powerful than current technologies used in hybrid electric vehicles (HEVs).

“The UltraBattery is a leap forward for low emission transport and uptake of HEVs,” said David Lamb, who leads low emissions transport research with the Energy Transformed National Research Flagship.

“Previous tests show the UltraBattery has a life cycle that is at least four times longer and produces 50 per cent more power than conventional battery systems. It’s also about 70 per cent cheaper than the batteries currently used in HEVs,” he said.

By marrying a conventional fuel-powered engine with a battery to drive an electric motor, HEVs achieve the dual environmental benefit of reducing both greenhouse gas emissions and fossil fuel consumption.

The UltraBattery also has the ability to provide and absorb charge rapidly during vehicle acceleration and braking, making it particularly suitable for HEVs, which rely on the electric motor to meet peak power needs during acceleration and can recapture energy normally wasted through braking to recharge the battery.

Over the past 12 months, a team of drivers has put the UltraBattery to the test at the Millbrook Proving Ground in the United Kingdom, one of Europe’s leading locations for the development and demonstration of land vehicles.

“Passing the 100,000 miles mark is strong evidence of the UltraBattery's capabilities,” Mr Lamb said.
“CSIRO’s ongoing research will further improve the technology’s capabilities, making it lighter, more efficient and capable of setting new performance standards for HEVs.”

The UltraBattery test program for HEV applications is the result of an international collaboration. The battery system was developed by CSIRO in Australia, built by the Furukawa Battery Company of Japan and tested in the United Kingdom through the American-based Advanced Lead-Acid Battery Consortium.

UltraBattery technology also has applications for renewable energy storage from wind and solar. CSIRO is part of a technology start-up that will develop and commercialise battery-based storage solutions for these energy sources.

Source: CSIRO

Explore further: Solar-powered two-seat Sunseeker airplane has progress report

add to favorites email to friend print save as pdf

Related Stories

CSIRO's UltraBattery goes global in the auto sector

Oct 02, 2008

The CSIRO-invented UltraBattery is set to have a global impact on greenhouse gas emissions after Japan's Furukawa Battery Company, which has already begun production of the UltraBattery, and US manufacturer, East Penn, today ...

Recommended for you

Switch on sunlight for a brighter future

12 hours ago

Imagine sitting in a windowless room yet having the feeling of the sun shining on your face. This unique experience is now possible thanks to the COELUX EU-funded project which recreates the physical and ...

US urged to drop India WTO case on solar

Apr 23, 2014

Environmentalists Wednesday urged the United States to drop plans to haul India to the WTO to open its solar market, saying the action would hurt the fight against climate change.

Is nuclear power the only way to avoid geoengineering?

Apr 23, 2014

"I think one can argue that if we were to follow a strong nuclear energy pathway—as well as doing everything else that we can—then we can solve the climate problem without doing geoengineering." So says Tom Wigley, one ...

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.